In an article written for Law360, partners Rebecca Dandeker and Aliza Karetnick and associate Rachel Lamparelli discuss a citizen petition to the US Food and Drug Administration (FDA) and litigation tied to concerns about the presence of the chemical benzene in acne products containing benzoyl peroxide. The article notes that while awaiting further guidance from the FDA, affected manufacturers should consider steps such as assembling internal data and possibly contacting the FDA for product-specific discussions.